Doctor reveals what you should always do two hours before flying to avoid getting sick
Travelers should pop zinc and vitamin C two hours before arriving at crowded transit hubs like airports and bus terminals, according to Wyoming-based hospital physician Dr. Steve Burgess.
Airplanes, trains, and buses pack numerous people into enclosed spaces with recirculated air, and adding the stress of travel, interrupted sleep and exposure to new environments creates the 'perfect storm' of conditions to weaken the immune system.
Taking the germ-blasting supplements within the crucial window is a critical component that often goes ignored and gives your immune system a targeted boost to battle a bug when it needs it most, explained Burgess, who often sees physicians fall ill at the medical conferences he leads for CME Vacations.
'Think of it like putting up your umbrella right before walking into the rain, rather than waiting until you're already soaked,' he said. 'These supplements temporarily enhance certain immune functions, but that enhancement only lasts for a few hours.'
For long journeys with connections, consider taking another dose before each new flight or train ride, the doc added, but within reason.
'I've seen many common misconceptions among travelers — from mega-dosing vitamins throughout entire trips to exclusively blaming airplane air quality while ignoring surface contact,' said Burgess.
Zinc helps prevent viruses from multiplying and infecting the respiratory tract, and even has anti-inflammatory and antioxidant properties that can protect against autoimmune diseases and allergies.
Taking zinc within 24 hours of onset can help reduce the duration and severity of colds, studies show.
Another tip is to take zinc lozenges rather than tablets. The lozenges give the mighty mineral direct contact with the throat and respiratory tract, where many infections begin.
Vitamin C boosts various cellular functions of the immune system that help prevent infections.
'It doesn't require expensive supplements or complicated regimens,' Burgess noted. 'Just common, affordable supplements taken at precisely the right time.'
He recommends taking 15 to 25 milligrams of zinc and 500 to 1000 milligrams of vitamin C.
Constant high doses can cause digestive issues, he added, and hand washing remains necessary.
Also, keeping hydrated will help the supplements work more effectively and counters the dehydrating effects of flying.
His tips come as a record-breaking 45 million-plus people will travel at least 50 miles from home over Memorial Day Weekend, many by plane, train, bus and on cruises, AAA announced this week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
9 hours ago
- Indianapolis Star
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@
Business Insider
11 hours ago
- Business Insider
Real estate investors say mid-term rentals are the 'sweet spot,' offering a way around Airbnb red tape and more cash flow than long-term rentals
When the COVID pandemic erased virtually all of Zeona McIntyre's Airbnb bookings, she found a solution in mid-term rentals. "I was really open to doing whatever I needed to get my properties rented," the Colorado-based property investor told Business Insider. She started listing her properties on Furnished Finder, which is geared toward traveling professionals and specializes in 30-day plus stays, and was surprised by the hit rate and relative ease of the process. "I realized there are tons of people looking all the time for longer stays — and longer stays are kind of awesome because people don't need as much from you. They're OK to go buy their own toilet paper and change the batteries because they're living there." What started as an attempt to combat Airbnb vacancies evolved into her preferred rental strategy. "My bread-and-butter is these mid-term rentals," said McIntyre, who is the author of " 30-Day Stay." "I want a longer tenant in there, and I don't want to have to think about it for three months." Massachusetts-based investor Dana Bull also pivoted to mid-term rentals, but for a different reason: to withstand rising interest rates. The average 30-year fixed mortgage rate surged to 8% in 2023 and lingered in the 6s and 7s in 2024. Higher interest rates mean higher monthly payments, which can eat into an investor's cash flow. Bull has been renting to long-term tenants for more than a decade, but to make the numbers work on her most recent acquisition, a charming single-family home she found in 2023 and couldn't pass up, she turned to mid-term rentals, which she says are more time-intensive, but also more profitable. The 'sweet spot' of rentals Real estate investors tend to agree that, while long-term rentals can produce consistent, relatively passive income, these leases generate less revenue a month compared to short-term rentals. However, short-term rental properties present unique challenges, such as constant tenant turnover, managing multiple bookings, and ever-evolving country-specific rules and regulations. Then, there are mid-term rentals — or, the "sweet spot" of real-estate investing, according to McIntyre — which are properties listed for longer than 30 days but less than a year. In her experience, they're "a whole different vibe from short-term rentals and way less stressful." One major stressor she faced in hosting on Airbnb and VRBO was the evolving rules around permits and licenses. "Short-term rentals have been under scrutiny, and the ever-tightening regulations are constantly changing," she said. "But there is sort of this magic number that, as soon as a listing is over 30 days, these rentals get classified into a long-term rental bucket and then you don't have the extra taxes or have to have a short-term rental permit." That was a contributing factor in Manny Reyna's decision to incorporate mid-term rentals into his overall strategy. "Within San Antonio, you need an STR permit through the city," said Reyna, who rents two single-family homes and two tiny homes in the San Antonio metro. "The permit is $450 just to apply, and you have to pay county taxes and city taxes on the revenue. It's called a hotel tax, and it's really high." However, if you're listing a 30-day stay, "you don't necessarily have to worry about the STR taxes," said Reyna. "It's a little bit of a loophole, if you will. It's also a good middle ground, because the cash flow is higher than long-term rentals." That said, hosting mid-term stays will require upfront work. You're catering to a completely different customer, and leasing can be a challenge because mid-term rentals are less mainstream, explained Bull. "If you want a long-term rental, you know you're going to be on Zillow or work with a real-estate agent. If you want a short-term rental, you also have set channels: You have Airbnb, Vrbo." The equivalent for mid-term rentals is Furnished Finder, "but it's not very well known, and it's not nearly as big as something like Airbnb," she said. A hybrid approach While Reyna prefers mid-term tenants, he wants to cater to a broad customer base and still lists his properties on Airbnb, VRBO, Hipcamp, and Facebook Marketplace when there's a gap between mid-term tenants. "I try to do a shotgun approach to see who's going to bite first," he said. Seattle-based investor Peter Keane-Rivera also uses a hybrid model for his 70s-themed " Groovy Guest House," which he initially listed exclusively as a short-term vacation rental. He enjoys the work that goes into managing a short-term rental — "it does allow you to provide a unique service and really to have control over the quality of that service," he said — but offering 30-plus day stays will generate more consistent revenue during the slow season when people are traveling less. "In the summertime, it pulls in a lot — in June and July, I made almost $5,000 on a one-bedroom in the outskirts of Seattle," he said, referring to the Airbnb income. "But in the wintertime, there are lower margins. I'd rather get something closer to market rent rates, not have to worry about it for four to five months during the slowest seasons, and then spin it back up for spring, summer, and fall to maximize the return." Toggling between short- and mid-term rentals is "a real asset," he said, adding that if he expands to a second Airbnb unit, he'd use the same strategy. "For eight months out of the year, I'd run it as an Airbnb and then during the low season, run it as a mid-term rental."
Boston Globe
12 hours ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
